Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib Tablet vs Capsule Bioequivalence in Advanced Solid Tumors
NCT03329001Phase 1Completed
- Start
- Dec 2017
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of niraparib in solid tumor. Started Dec 2017; status: completed.
02
Drugs
niraparib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03329001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03329001.